{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:04:13Z","timestamp":1792015453029,"version":"4.4.0"},"reference-count":197,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Neoplastic diseases represent one of the most common causes of death among humans and animals. Currently available and applied therapeutic options often remain insufficient and unsatisfactory, therefore new and innovative strategies and approaches are highly needed. Periodically, oncolytic viruses have been in the center of interest since the first anecdotal description of their potential usefulness as an anti-tumor treatment concept. Though first reports referred to an incidental measles virus infection causing tumor regression in a patient suffering from lymphoma several decades ago, no final treatment concept has been developed since then. However, numerous viruses, such as herpes-, adeno- and paramyxoviruses, have been investigated, characterized, and modified with the aim to generate a new anti-cancer treatment option. Among the different viruses, measles virus still represents a highly interesting candidate for such an approach. Numerous different tumors of humans including malignant lymphoma, lung and colorectal adenocarcinoma, mesothelioma, and ovarian cancer, have been studied in vitro and in vivo as potential targets. Moreover, several concepts using different virus preparations are now in clinical trials in humans and may proceed to a new treatment option. Surprisingly, only few studies have investigated viral oncolysis in veterinary medicine. The close relationship between measles virus (MV) and canine distemper virus (CDV), both are morbilliviruses, and the fact that numerous tumors in dogs exhibit similarities to their human counterpart, indicates that both the virus and species dog represent a highly interesting translational model for future research in viral oncolysis. Several recent studies support such an assumption. It is therefore the aim of the present communication to outline the mechanisms of morbillivirus-mediated oncolysis and to stimulate further research in this potentially expanding field of viral oncolysis in a highly suitable translational animal model for the benefit of humans and dogs.<\/jats:p>","DOI":"10.3390\/v6062340","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T11:59:22Z","timestamp":1402487962000},"page":"2340-2375","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Viral Oncolysis \u2014 Can Insights from Measles Be Transferred to Canine Distemper Virus?"],"prefix":"10.3390","volume":"6","author":[{"given":"Stefanie","family":"Lapp","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Veterinary Medicine Hannover, B\u00fcnteweg 17, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pfankuche","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Veterinary Medicine Hannover, B\u00fcnteweg 17, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Baumg\u00e4rtner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Veterinary Medicine Hannover, B\u00fcnteweg 17, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Puff","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Veterinary Medicine Hannover, B\u00fcnteweg 17, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1748-5827.2010.00974.x","article-title":"Methods and mortality results of a health survey of purebred dogs in the UK","volume":"51","author":"Adams","year":"2010","journal-title":"J. Small Anim. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-5877(03)00010-2","article-title":"Mortality of purebred and mixed-breed dogs in denmark","volume":"58","author":"Proschowsky","year":"2003","journal-title":"Prev. Vet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5810.2006.00090.x","article-title":"Histiocytic sarcomas in flat-coated retrievers: A summary of 37 cases (November 1998-March 2005)","volume":"4","author":"Fidel","year":"2006","journal-title":"Vet. Comp. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2407-11-201","article-title":"Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior","volume":"11","author":"Hedan","year":"2011","journal-title":"BMC Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000340066","article-title":"Histiocytic sarcoma - targeted therapy: Novel therapeutic options? A series of 4 cases","volume":"35","author":"Schlick","year":"2012","journal-title":"Onkologie"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","article-title":"Extranodal histiocytic sarcoma: Clinicopathologic analysis of 14 cases of a rare epithelioid malignancy","volume":"28","author":"Hornick","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1102\/1470-7330.2012.0029","article-title":"Imaging features of primary extranodal histiocytic sarcoma: Report of two cases and a review of the literature","volume":"12","author":"Saboo","year":"2012","journal-title":"Cancer Imaging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3748\/wjg.v20.i4.943","article-title":"Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer","volume":"20","author":"Lopomo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"327A","DOI":"10.1378\/chest.1822395","article-title":"Five year lung cancer survival (2004\u20132007) from hospital virgen de las nieves in granada","volume":"145","year":"2014","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jso.23409","article-title":"Does long-term survival in patients with pancreatic cancer really exist? Results from the conko-001 study","volume":"108","author":"Sinn","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0002-9610(69)90141-X","article-title":"Clinical advances in the treatment of cancer","volume":"118","author":"Goldsmith","year":"1969","journal-title":"Am. J. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: An update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3322\/caac.21209","article-title":"Progress and controversies: Radiation therapy for invasive breast cancer","volume":"64","author":"Jagsi","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5326\/0420361","article-title":"The use of complementary and alternative therapies in dogs and cats with cancer","volume":"42","author":"Lana","year":"2006","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-5876-10-3","article-title":"Oncolytic virotherapy in veterinary medicine: Current status and future prospects for canine patients","volume":"10","author":"Patil","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5326\/JAAHA-MS-5525","article-title":"Treatment with DAV for advanced-stage hemangiosarcoma in dogs","volume":"47","author":"Dervisis","year":"2011","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tvjl.2010.04.027","article-title":"The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects","volume":"188","author":"Marconato","year":"2011","journal-title":"Vet. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/CJI.0b013e31829d8a1b","article-title":"Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma","volume":"36","author":"Westberg","year":"2013","journal-title":"J. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(71)92086-1","article-title":"Regression of Burkitt's lymphoma in association with measles infection","volume":"2","author":"Bluming","year":"1971","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(81)92286-8","article-title":"Regression of Hodgkin's disease after measles","volume":"1","author":"Taqi","year":"1981","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(71)91186-X","article-title":"Hodgkin's disease: Remissions after measles","volume":"1","author":"Zygiert","year":"1971","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.canlet.2012.07.008","article-title":"Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human neuroblastoma through a CD46 and nectin 4-independent pathway","volume":"325","author":"Zhang","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/1471-2407-12-427","article-title":"Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma","volume":"12","author":"Zhang","year":"2012","journal-title":"BMC Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3892\/or.2012.2109","article-title":"Live attenuated measles virus vaccine induces apoptosis and promotes tumor regression in lung cancer","volume":"29","author":"Zhao","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","article-title":"The yin-yang of tumor-associated macrophages in neoplastic progression and immune surveillance","volume":"222","author":"Allavena","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.ejca.2004.03.016","article-title":"Tumour-associated macrophages as a prototypic type II polarised phagocyte population: Role in tumour progression","volume":"40","author":"Mantovani","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.semcancer.2012.02.002","article-title":"Differentiation and gene expression profile of tumor-associated macrophages","volume":"22","author":"Schmieder","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-824X-5-20","article-title":"The role of tumor-associated macrophages in tumor vascularization","volume":"5","author":"Guo","year":"2013","journal-title":"Vasc. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","article-title":"\"Re-educating\" tumor-associated macrophages by targeting NF-kappaB","volume":"205","author":"Hagemann","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple defects of immune cell function in mice with disrupted interferon-gamma genes","volume":"259","author":"Dalton","year":"1993","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00262-002-0294-2","article-title":"Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin","volume":"51","author":"Yao","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V96.5.1900","article-title":"Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12","volume":"96","author":"Yao","year":"2000","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V93.5.1612","article-title":"Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12","volume":"93","author":"Yao","year":"1999","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.182.1.155","article-title":"Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo","volume":"182","author":"Angiolillo","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V87.9.3877.bloodjournal8793877","article-title":"Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10","volume":"87","author":"Sgadari","year":"1996","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e32803","DOI":"10.1371\/journal.pone.0032803","article-title":"Morbillivirus glycoprotein expression induces ER stress, alters Ca2+ homeostasis and results in the release of vasostatin","volume":"7","author":"Brunner","year":"2012","journal-title":"PLoS One"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.188.12.2349","article-title":"Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth","volume":"188","author":"Pike","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood.V94.7.2461.419a26_2461_2468","article-title":"Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth","volume":"94","author":"Pike","year":"1999","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ctrv.2010.12.003","article-title":"The emerging role of viruses in the treatment of solid tumours","volume":"37","author":"Bourke","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nrc948","article-title":"Oncolytic viruses","volume":"2","author":"Chiocca","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: A century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_45","first-page":"43","article-title":"Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: An overview","volume":"11","author":"Msaouel","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2174\/138920112800958896","article-title":"Attenuated oncolytic measles virus strains as cancer therapeutics","volume":"13","author":"Msaouel","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14712598.2013.749851","article-title":"Oncolytic measles virus strains as novel anticancer agents","volume":"13","author":"Msaouel","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"Anderson","year":"2004","journal-title":"Cancer Res."},{"key":"ref_50","first-page":"213","article-title":"Measles virus for cancer therapy","volume":"330","author":"Russell","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1158\/0008-5472.CAN-12-2221","article-title":"Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus","volume":"73","author":"Bach","year":"2013","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2008.08.003","article-title":"Cancer stem cell markers in common cancers - therapeutic implications","volume":"14","author":"Klonisch","year":"2008","journal-title":"Trends Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2003-07-2233","article-title":"Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter","volume":"103","author":"Dingli","year":"2004","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1471-2407-12-508","article-title":"Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine","volume":"12","author":"Hutzen","year":"2012","journal-title":"BMC Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1016\/j.vaccine.2013.05.056","article-title":"Oncolytic myxoma virus: The path to clinic","volume":"31","author":"Chan","year":"2013","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e73555","DOI":"10.1371\/journal.pone.0073555","article-title":"Oncolytic reovirus in canine mast cell tumor","volume":"8","author":"Hwang","year":"2013","journal-title":"PLoS One"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2174\/138920112800958814","article-title":"Oncolytic hsv-1 virotherapy: Clinical experience and opportunities for progress","volume":"13","author":"Kaur","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1358\/dnp.2009.22.3.1354090","article-title":"Clinical trial design for adenoviral gene therapy products","volume":"22","author":"Shirakawa","year":"2009","journal-title":"Drug News Perspect."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14712598.2010.495383","article-title":"Herpes simplex virus oncolytic vaccine therapy in melanoma","volume":"10","author":"Sivendran","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in china","volume":"7","author":"Yu","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jnci\/djj111","article-title":"China approves world's first oncolytic virus therapy for cancer treatment","volume":"98","author":"Garber","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2008.09.023","article-title":"Pathogenesis and immunopathology of systemic and nervous canine distemper","volume":"127","author":"Beineke","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/vir.0.82221-0","article-title":"Measles virus: Cellular receptors, tropism and pathogenesis","volume":"87","author":"Yanagi","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_65","unstructured":"Lamb, R.A., and Kolakofsky, D. (2001). Paramyxoviridae: The Viruses and Their Replication, Lippincott Williams&Wilkins. [4th ed.]."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sbi.2007.08.016","article-title":"Structural basis of viral invasion: Lessons from paramyxovirus f","volume":"17","author":"Lamb","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-1135(90)90145-L","article-title":"Morbillivirus group: Genome organisation and proteins","volume":"23","author":"Diallo","year":"1990","journal-title":"Vet. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virusres.2007.07.004","article-title":"Synergistic inhibition in cell-cell fusion mediated by the matrix and nucleocapsid protein of canine distemper virus","volume":"129","author":"Wiener","year":"2007","journal-title":"Virus Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.coviro.2012.03.005","article-title":"The pathogenesis of measles","volume":"2","author":"Mesman","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1566524013363960","article-title":"Measles virus induced immunosuppression: Targets and effector mechanisms","volume":"1","author":"Niewiesk","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1160\/TH09-03-0202","article-title":"Systemic spread of measles virus: Overcoming the epithelial and endothelial barriers","volume":"102","author":"Ludlow","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/JVI.75.10.4499-4505.2001","article-title":"CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition","volume":"75","author":"Erlenhoefer","year":"2001","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1073\/pnas.93.23.13194","article-title":"Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro","volume":"93","author":"Schlender","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/JVI.01559-09","article-title":"Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150)","volume":"84","author":"Ferreira","year":"2010","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1099\/0022-1317-72-2-439","article-title":"Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion","volume":"72","author":"Wild","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_77","first-page":"2448","article-title":"Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed","volume":"118","author":"Leonard","year":"2008","journal-title":"J. Clin. Invest."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Mateo","year":"2011","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.ppat.1002240","article-title":"Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus","volume":"7","author":"Noyce","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"Marcil","year":"1993","journal-title":"Cell"},{"key":"ref_81","first-page":"26","article-title":"Virale Infektionskrankheiten bei Welpen und Junghunden unter besonderer Ber\u00fccksichtigung der Staupevirusinfektion","volume":"74","year":"1993","journal-title":"Prakt. Tierarzt."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/030098588101800513","article-title":"Lesions of the enamel organ of developing dog teeth following experimental inoculation of gnotobiotic puppies with canine distemper virus","volume":"18","author":"Dubielzig","year":"1981","journal-title":"Vet. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/104063870902100502","article-title":"Molecular detection of canine distemper virus and the immunohistochemical characterization of the neurologic lesions in naturally occurring old dog encephalitis","volume":"21","author":"Headley","year":"2009","journal-title":"J. Vet. Diagn. Invest."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1354\/vp.41-1-2","article-title":"Histopathology and immunohistochemistry of canine distemper virus-induced footpad hyperkeratosis (hard pad disease) in dogs with natural canine distemper","volume":"41","author":"Koutinas","year":"2004","journal-title":"Vet. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2990.1994.tb01006.x","article-title":"Aspects of canine distemper virus and measles virus encephalomyelitis","volume":"20","author":"Summers","year":"1994","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2460\/javma.1970.156.12.1681","article-title":"Distemper pathogenesis in dogs","volume":"156","author":"Appel","year":"1970","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.0403597101","article-title":"Tropism illuminated: Lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system","volume":"101","author":"Milosevic","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1128\/JVI.00824-12","article-title":"Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence","volume":"86","author":"Pratakpiriya","year":"2012","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1078-0432.CCR-04-1944","article-title":"In vitro canine distemper virus infection of canine lymphoid cells: A prelude to oncolytic therapy for lymphoma","volume":"11","author":"Suter","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/JVI.75.13.5842-5850.2001","article-title":"Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors","volume":"75","author":"Tatsuo","year":"2001","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1354\/vp.44-6-943","article-title":"Immunohistochemical demonstration of the putative canine distemper virus receptor CD150 in dogs with and without distemper","volume":"44","author":"Wenzlow","year":"2007","journal-title":"Vet. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1128\/JVI.79.9.5857-5862.2005","article-title":"Nearby clusters of hemagglutinin residues sustain slam-dependent canine distemper virus entry in peripheral blood mononuclear cells","volume":"79","author":"Oezguen","year":"2005","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1128\/JVI.01077-10","article-title":"Identification of key residues in virulent canine distemper virus hemagglutinin that control CD150\/SLAM-binding activity","volume":"84","author":"Zipperle","year":"2010","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2012.11.011","article-title":"Dog nectin-4 is an epithelial cell receptor for canine distemper virus that facilitates virus entry and syncytia formation","volume":"436","author":"Noyce","year":"2013","journal-title":"Virology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JVI.02632-12","article-title":"Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters","volume":"87","author":"Watanabe","year":"2013","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1542\/peds.2011-1430","article-title":"The first measles vaccine","volume":"128","author":"Baker","year":"2011","journal-title":"Pediatrics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/jvi.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus","volume":"67","author":"Naniche","year":"1993","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"32294","DOI":"10.1074\/jbc.M202973200","article-title":"Distinct kinetics for binding of the CD46 and slam receptors to overlapping sites in the measles virus hemagglutinin protein","volume":"277","author":"Santiago","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1128\/JVI.76.15.7460-7467.2002","article-title":"Efficiency of measles virus entry and dissemination through different receptors","volume":"76","author":"Schneider","year":"2002","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.2011.04400.x","article-title":"CD46 in innate and adaptive immunity: An update","volume":"164","author":"Cardone","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0161-5890(03)00112-3","article-title":"Obstacles to cancer immunotherapy: Expression of membrane complement regulatory proteins (mCRPs) in tumors","volume":"40","author":"Fishelson","year":"2003","journal-title":"Mol. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","article-title":"Nectin 4 overexpression in ovarian cancer tissues and serum: Potential role as a serum biomarker","volume":"134","author":"Derycke","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-7-73","article-title":"Nectin-4 is a new histological and serological tumor associated marker for breast cancer","volume":"7","author":"Monville","year":"2007","journal-title":"BMC Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","article-title":"Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer","volume":"69","author":"Takano","year":"2009","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.V98.7.2002","article-title":"Systemic therapy of myeloma xenografts by an attenuated measles virus","volume":"98","author":"Peng","year":"2001","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V97.12.3746","article-title":"Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice","volume":"97","author":"Grote","year":"2001","journal-title":"Blood"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/387362","article-title":"Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas","volume":"2013","author":"Boisgerault","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/mt.2011.65","article-title":"Thunder and lightning: Immunotherapy and oncolytic viruses collide","volume":"19","author":"Melcher","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/gt.2011.205","article-title":"Measles virus causes immunogenic cell death in human melanoma","volume":"20","author":"Donnelly","year":"2013","journal-title":"Gene Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/0008-5472.CAN-07-6265","article-title":"Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response","volume":"68","author":"Gauvrit","year":"2008","journal-title":"Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e24212","DOI":"10.4161\/onci.24212","article-title":"Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells","volume":"2","author":"Fonteneau","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-12-2733","article-title":"Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells","volume":"19","author":"Guillerme","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JVI.02106-12","article-title":"Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis","volume":"87","author":"Berchtold","year":"2013","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1158\/1078-0432.CCR-07-1306","article-title":"Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme","volume":"13","author":"Liu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"Nakamura","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1128\/JVI.74.21.9928-9936.2000","article-title":"Recombinant measles viruses efficiently entering cells through targeted receptors","volume":"74","author":"Schneider","year":"2000","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1128\/JVI.75.5.2087-2096.2001","article-title":"Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen","volume":"75","author":"Hammond","year":"2001","journal-title":"J. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/157489212801820020","article-title":"Carcinoembryonic antigen (CEA)-based cancer vaccines: Recent patents and antitumor effects from experimental models to clinical trials","volume":"7","author":"Turriziani","year":"2012","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues","volume":"9","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/JVI.78.1.302-313.2004","article-title":"Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model","volume":"78","author":"Vongpunsawad","year":"2004","journal-title":"J. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood-2002-07-2195","article-title":"Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker","volume":"101","author":"Peng","year":"2003","journal-title":"Blood"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1525-0016(02)00033-3","article-title":"An oncolytic measles virus engineered to enter cells through the CD20 antigen","volume":"7","author":"Bucheit","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Press, O.W., Leonard, J.P., Coiffier, B., Levy, R., and Timmerman, J. (2001). Immunotherapy of non-Hodgkin's lymphomas. Hematology Am. Soc. Hematol. Educ. Program., 221\u2013240.","DOI":"10.1182\/asheducation-2001.1.221"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1158\/0008-5472.CAN-06-0538","article-title":"Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases","volume":"66","author":"Springfeld","year":"2006","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s13277-013-0842-8","article-title":"Matrix metalloproteinases in cancer: Their value as diagnostic and prognostic markers and therapeutic targets","volume":"34","author":"Winberg","year":"2013","journal-title":"Tumour. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/jvi.69.5.3206-3210.1995","article-title":"Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus","volume":"69","author":"Watanabe","year":"1995","journal-title":"J. Virol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1158\/0008-5472.CAN-09-4650","article-title":"Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus","volume":"70","author":"Schaser","year":"2010","journal-title":"Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/mt.2008.130","article-title":"A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication","volume":"16","author":"Edge","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/nm.1776","article-title":"Engineering microRNA responsiveness to decrease virus pathogenicity","volume":"14","author":"Kelly","year":"2008","journal-title":"Nat. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/JVI.01788-09","article-title":"Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting","volume":"84","author":"Kelly","year":"2009","journal-title":"J. Virol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1158\/1078-0432.CCR-09-0051","article-title":"MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells","volume":"15","author":"Lee","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1128\/JVI.01608-08","article-title":"Generation of a conditionally replicating adenovirus based on targeted destruction of e1a mRNA by a cell type-specific microRNA","volume":"82","author":"Hakkarainen","year":"2008","journal-title":"J. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/mt.2011.55","article-title":"MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism","volume":"19","author":"Leber","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nm0502-527","article-title":"Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides","volume":"8","author":"Peng","year":"2002","journal-title":"Nat. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/hep.21437","article-title":"Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma","volume":"44","author":"Blechacz","year":"2006","journal-title":"Hepatology"},{"key":"ref_137","first-page":"4656","article-title":"Intraperitoneal therapy of ovarian cancer using an engineered measles virus","volume":"62","author":"Peng","year":"2002","journal-title":"Cancer Res."},{"key":"ref_138","first-page":"2462","article-title":"Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme","volume":"63","author":"Phuong","year":"2003","journal-title":"Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/cgt.2010.10","article-title":"Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/jid.2012.459","article-title":"Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus","volume":"133","author":"Kaufmann","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1089\/hum.2012.136","article-title":"A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma","volume":"24","author":"Lange","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/gt.2013.28","article-title":"An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis","volume":"20","author":"Lampe","year":"2013","journal-title":"Gene Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/humc.2012.242","article-title":"Intrahepatic application of suicide gene-armed measles virotherapeutics: A safety study in transgenic mice and rhesus macaques","volume":"24","author":"Bach","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"ref_144","first-page":"6463","article-title":"Neutrophils contribute to the measles virus-induced antitumor effect: Enhancement by granulocyte macrophage colony-stimulating factor expression","volume":"63","author":"Grote","year":"2003","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1089\/hum.2012.205","article-title":"Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine","volume":"24","author":"Grossardt","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1286-4579(02)01583-6","article-title":"Mechanisms of inhibition of the host interferon alpha\/beta-mediated antiviral responses by viruses","volume":"4","year":"2002","journal-title":"Microbes Infect."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.mt.6300076","article-title":"Engineering oncolytic measles virus to circumvent the intracellular innate immune response","volume":"15","author":"Haralambieva","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.cgt.7700823","article-title":"Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer","volume":"12","author":"Myers","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/blood-2004-11-4558","article-title":"Oncolytic measles virus in cutaneous t-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells","volume":"106","author":"Heinzerling","year":"2005","journal-title":"Blood"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mt.2011.44","article-title":"Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights","volume":"19","author":"Patel","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cas.12324","article-title":"Enhanced susceptibility of B lymphoma cells to measles virus by Epstein-Barr virus type III latency that upregulates CD150\/signaling lymphocytic activation molecule","volume":"105","author":"Takeda","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-006-9200-5","article-title":"A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer","volume":"99","author":"McDonald","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.mt.6300020","article-title":"Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy","volume":"15","author":"Iankov","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/gt.2008.30","article-title":"Heat shock protein inhibitors increase the efficacy of measles virotherapy","volume":"15","author":"Liu","year":"2008","journal-title":"Gene Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/mt.2009.218","article-title":"Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter","volume":"17","author":"Msaouel","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-09-2762","article-title":"Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer","volume":"70","author":"Galanis","year":"2010","journal-title":"Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/gt.2012.62","article-title":"Oncolytic measles virus strains have significant antitumor activity against glioma stem cells","volume":"20","author":"Allen","year":"2013","journal-title":"Gene Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.cgt.7700948","article-title":"Pharmacokinetics of oncolytic measles virotherapy: Eventual equilibrium between virus and tumor in an ovarian cancer xenograft model","volume":"13","author":"Peng","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1158\/1078-0432.CCR-05-1803","article-title":"Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"13149","DOI":"10.1128\/JVI.01415-07","article-title":"Affinity thresholds for membrane fusion triggering by viral glycoproteins","volume":"81","author":"Hasegawa","year":"2007","journal-title":"J. Virol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1158\/0008-5472.CAN-06-1200","article-title":"Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity","volume":"66","author":"Allen","year":"2006","journal-title":"Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/pros.20962","article-title":"Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer","volume":"69","author":"Liu","year":"2009","journal-title":"Prostate"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.clpt.6100409","article-title":"Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide","volume":"82","author":"Myers","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2214\/AJR.08.1205","article-title":"Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene","volume":"192","author":"Carlson","year":"2009","journal-title":"Am. J. Roentgenol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pros.20857","article-title":"Engineered measles virus as a novel oncolytic therapy against prostate cancer","volume":"69","author":"Msaouel","year":"2009","journal-title":"Prostate"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/mt.2010.43","article-title":"Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers","volume":"18","author":"Liu","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2214\/AJR.09.3672","article-title":"Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer","volume":"195","author":"Penheiter","year":"2010","journal-title":"Am. J. Roentgenol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/cgt.2011.82","article-title":"Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus","volume":"19","author":"Liu","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/hum.2011.158","article-title":"Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS)","volume":"23","author":"Opyrchal","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/hum.2011.128","article-title":"Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy","volume":"23","author":"Li","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2013.05.036","article-title":"Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition","volume":"108","author":"Touchefeu","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2013.11.010","article-title":"Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer","volume":"132","author":"Liu","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1038\/sj.jid.5700529","article-title":"Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo","volume":"126","author":"Oberholzer","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/mt.2008.152","article-title":"Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity","volume":"16","author":"Allen","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1158\/0008-5472.CAN-04-2879","article-title":"Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression","volume":"65","author":"Hallak","year":"2005","journal-title":"Cancer Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/mt.2009.39","article-title":"Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo","volume":"17","author":"Ong","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/mt.2009.92","article-title":"Converting tumor-specific markers into reporters of oncolytic virus infection","volume":"17","author":"Iankov","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/mt.2012.4","article-title":"Expression of immunomodulatory neutrophil-activating protein of helicobacter pylori enhances the antitumor activity of oncolytic measles virus","volume":"20","author":"Iankov","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2013.05.004","article-title":"Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase","volume":"130","author":"Hartkopf","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Yurttas, C., Berchtold, S., Malek, N., Bitzer, M., and Lauer, U.M. (2014). \"PULSED\" versus \"CONTINUOUS\" application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Hum. Gene Ther. Clin. Dev.","DOI":"10.1089\/hum.2013.127"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/mt.2013.16","article-title":"DARPin-targeting of measles virus: Unique bispecificity, effective oncolysis, and enhanced safety","volume":"21","author":"Friedrich","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_182","unstructured":"ClincialTrial.gov. Available online:http:\/\/www.clinicaltrials.gov\/."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Russell, S.J., Federspiel, M.J., Peng, K.W., Tong, C., Dingli, D., Morice, W.G., Lowe, V., O'Connor, M.K., Kyle, R.A., and Leung, N. (2014). Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clin. Proc.","DOI":"10.1016\/j.mayocp.2014.04.003"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0065-3527(08)00004-3","article-title":"Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation","volume":"71","year":"2008","journal-title":"Adv. Virus Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","article-title":"Genetic characterization of measles vaccine strains","volume":"204","author":"Bankamp","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1128\/JVI.00051-11","article-title":"Canine distemper virus matrix protein influences particle infectivity, particle composition, and envelope distribution in polarized epithelial cells and modulates virulence","volume":"85","author":"Dietzel","year":"2011","journal-title":"J. Virol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/1743-422X-8-334","article-title":"Canine distemper virus induces apoptosis in cervical tumor derived cell lines","volume":"8","author":"Martins","year":"2011","journal-title":"Virol. J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tvjl.2008.03.026","article-title":"Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage\/monocytic tumour cell line (DH82)","volume":"182","author":"Puff","year":"2009","journal-title":"Vet. J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1292\/jvms.67.203","article-title":"Growth characteristics of canine distemper virus in a new cell line CCT cells originated from canine malignant histiocytosis","volume":"67","author":"Yamaguchi","year":"2005","journal-title":"J. Vet. Med. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/088282402760312368","article-title":"Cell type-dependent cytokine expression after canine distemper virus infection","volume":"15","author":"Fonfara","year":"2002","journal-title":"Viral. Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","article-title":"Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion","volume":"20","author":"Bourboulia","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2174\/187152012802650237","article-title":"Recking mmp: Relevance of reversion-inducing cysteine-rich protein with Kazal motifs as a prognostic marker and therapeutic target for cancer (a review)","volume":"12","author":"Nagini","year":"2012","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1023043315031","article-title":"Reck: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling","volume":"22","author":"Noda","year":"2003","journal-title":"Cancer Metastasis. Rev."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.10329","article-title":"Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets","volume":"99","author":"Vihinen","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3892\/ol.2013.1306","article-title":"Reversion-inducing cysteine-rich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma","volume":"5","author":"Mao","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.humpath.2011.10.012","article-title":"Reversion-inducing cysteine-rich protein with kazal motif (RECK) expression: An independent prognostic marker of survival in colorectal cancer","volume":"43","author":"Stenzinger","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3892\/ol.2014.1906","article-title":"Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis","volume":"7","author":"Zhou","year":"2014","journal-title":"Oncol. Lett."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/6\/6\/2340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:12:20Z","timestamp":1760217140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/6\/6\/2340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":197,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"alternative-id":["v6062340"],"URL":"https:\/\/doi.org\/10.3390\/v6062340","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}